GENETIC POLYMORPHISMS ASSOCIATED WITH THE RESPONSE AND TOXICITY OF EVEROLIMUS IN PATIENTS WITH METASTATIC BREAST CANCER (MBC): (RE+)(HER-)

OBSERVATIONAL STUDY WITH MEDICINES

Home · TEC02-Hospital Pharmacotherapeutic Follow-up

Clinical trial information

Promoter: Alejandro Otero Foundation for Biosanitary Research in Eastern Andalusia (FIBAO)
Execution start: 12/12/24
End of execution: 31/12/26
IP: ELIZABETH SPRUCE SPARTA